Efficacy of a new 7-day transdermal sequential estradiol/levonorgestrel patch in women

Maturitas

Volumn 41, Issue 3, 2002, Pages 231-242

  Von Holst, Thomas ^a   Salbach, Birgitt ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

7 Day estradiol patch; 7 Day estradiol levonorgestrel patch; Estradiol; Hormone replacement therapy; Kupperman index; Levonorgestrel; Transdermal sequential regimen

Indexed keywords

ESTRADIOL; FEM 7; LEVONORGESTREL; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENOPAUSE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; DOUBLE-BLIND METHOD; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; GERMANY; HOT FLASHES; HUMANS; LEVONORGESTREL; MENOPAUSE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0037170860     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(01)00297-3     Document Type: Article

References (39)

1. Postmenopausal hormone replacement therapy - Clinical implications
2. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses health study
3. Hormone therapy to prevent disease and prolong life in postmenopausal women
4. Transdermal estradiol: A review of its pharmacological profile and therapeutic potential in the prevention of postmenopausal osteoporosis
5. A decade of experience with transdermal estrogen replacement therapy: Overview of key pharmacologic and clinical findings
6. Effects of treatment with oestradiol/levonorgestrel on bone, lipoproteins and hormone status in postmenopausal women
7. Regular review. Postmenopausal hormone replacement therapy
8. Treatment of postmenopausal osteoporosis with transdermal estrogen
9. Current concepts in estrogen replacement therapy in the menopause
10. Drug development report (7). Hormone replacement therapy: A review
11. Newer HRT regimens
12. Non-oral routes of estrogen administration
13. Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure
14. An alternative regimen of hormone replacement therapy to improve patient compliance
15. Effects of low doses of transdermal 17β-estradiol on carbohydrate metabolism in postmenopausal women
16. Role of insulin resistance in human disease. Banting lecture
17. Hormonal replacement therapy: Benefits, risks, doses
18. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins
19. Serum lipids in treatment with transdermal estradiol and oral norethisterone acetate
20. Predominance of early endometrial cancers after long-term estrogen use
21. Estrogen replacement therapy and endometrial cancer risk: Unresolved issues
22. Long-term transdermal estradiol therapy: Effects on endometrial histology and bleeding patterns
23. Effects of hormone therapy on the endometrium
24. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: Results of a prospective study
25. Progestogen supplementation of exogenous oestrogens and risk of endometrial cancer
26. Comparative clinical evaluation of estrogen preparation by the postmenopausal and amenorrheal indices
27. Methods of the study of irritation and toxicity of substances applied topically to the skin and mucous membranes
28. Double-masked, multicenter study of an estradiol matrix transdermal delivery system (Alora) versus placebo in postmenopausal women experiencing menopausal symptoms
29. Efficacy and tolerability of Estraderm MX, a new estradiol matrix patch
30. Efficacy and acceptability of intranasal 17β-oestradiol for menopausal symptoms: Randomised dose-response study
31. Transdermal administration of oestrogen/progesterone hormone replacement therapy
32. Efficacy, tolerability and compliance of FemSeven, a once-weekly transdermal system, compared with Estraderm TTS 50
33. Long-term tolerability and efficacy of Fem7®, a once-weekly transdermal system, in women with post-menopausal complaints
34. Efficacy and tolerability of a new 7-day transdermal estradiol patch versus placebo in hysterectomized women with postmenopausal complaints
35. Serum lipids in postmenopausal or perimenopausal women using estrogen alone, estrogen with levonorgestel, or estrogen with norethisterone, compared with non users. Results from a cross-sectional study in two Norwegian counties 1985-1988
36. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy
37. Effects of hormone replacement therapy on weight, body composition, fat distribution and food intake in early postmenopausal women: A prospective study
38. Change in body weight, after hormone replacement therapy in postmenopausal women is dependent on basal circulating leptin
39. Current hormone replacement therapy: What are the shortcomings? Advances in delivery